India to Ecuador: Diltiazem Export Trade Route
India has recorded 9 verified shipments of Diltiazem exported to Ecuador, representing a combined trade value of $77.1K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $8.6K USD. The leading Indian exporter is CARITAS HEALTHCARE PRIVATE LIMITED , which accounts for 42% of total export value with 2 shipments worth $32.1K USD. On the buying side, TO THE PURCHASE MANAGER is the largest importer in Ecuador with $32.1K USD in purchases. The top 3 suppliers — CARITAS HEALTHCARE PRIVATE LIMITED , CARITAS HEALTHCARE PRIVATE LIMITED, STALLION LABORATORIES PVT LTD — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Ecuador Diltiazem corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $77.1K USD. The route is dominated by CARITAS HEALTHCARE PRIVATE LIMITED , which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's diltiazem manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $8.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with diltiazem's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #20 among India's top diltiazem export destinations globally.
On the import side, key buyers of Indian diltiazem in Ecuador include TO THE PURCHASE MANAGER , F.D.E.C.A, NORTH LIFE PHARMA ECUADOR NLF C.T. and 2 others. TO THE PURCHASE MANAGER is the single largest importer with 2 shipments valued at $32.1K USD.
Route Characteristics
- Average transit19 days
- Peak seasonQ2
- Primary modeSea freight
- Top portAHEMDABAD AIR ACC (INAMD4)
Market Position
- Global rank#20
- Annual growth+17.1%
- Demand growth+14.8%
- Regulatory ease74/100
Top 10 Indian Diltiazem Exporters to Ecuador
Showing top 10 of 4 Indian suppliers exporting Diltiazem to Ecuador, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CARITAS HEALTHCARE PRIVATE LIMITED Avg $16.1K per shipment | 2 | $32.1K | 41.7% |
| 2 | CARITAS HEALTHCARE PRIVATE LIMITED Avg $9.3K per shipment | 3 | $28.0K | 36.3% |
| 3 | STALLION LABORATORIES PVT LTD Avg $6.1K per shipment | 2 | $12.1K | 15.7% |
| 4 | HIRAL LABS LIMITED Avg $2.4K per shipment | 2 | $4.8K | 6.3% |
This table shows the top 10 of 4 Indian companies exporting diltiazem to Ecuador, ranked by total trade value. The listed exporters are: CARITAS HEALTHCARE PRIVATE LIMITED , CARITAS HEALTHCARE PRIVATE LIMITED, STALLION LABORATORIES PVT LTD, HIRAL LABS LIMITED. CARITAS HEALTHCARE PRIVATE LIMITED is the dominant supplier with 2 shipments worth $32.1K USD, giving it a 42% market share. The top 3 suppliers together account for 94% of the total trade value on this route.
Top 10 Diltiazem Importers in Ecuador
Showing top 10 of 5 known buyers in Ecuador receiving Diltiazem shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diltiazem in Ecuador include TO THE PURCHASE MANAGER , F.D.E.C.A, NORTH LIFE PHARMA ECUADOR NLF C.T., DIFARMEDIC CIA. LTDA., FDECA QUITO ECUADOR. The largest importer is TO THE PURCHASE MANAGER , accounting for $32.1K USD across 2 shipments — representing 42% of all diltiazem imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE PURCHASE MANAGER | 2 | $32.1K | 41.7% |
| 2 | F.D.E.C.A | 2 | $25.7K | 33.3% |
| 3 | NORTH LIFE PHARMA ECUADOR NLF C.T. | 2 | $12.1K | 15.7% |
| 4 | DIFARMEDIC CIA. LTDA. | 2 | $4.8K | 6.3% |
| 5 | FDECA QUITO ECUADOR | 1 | $2.3K | 3.0% |
Top 10 Diltiazem Formulations Imported by Ecuador
Showing top 10 of 8 product formulations shipped on the India to Ecuador Diltiazem route, ranked by trade value
Ecuador imports a wide range of diltiazem formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DILTIAZEM HYDROCHLORIDE TABLETS 60 MG B. — accounts for $32.1K USD across 2 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DILTIAZEM HYDROCHLORIDE TABLETS 60 MG B. | 2 | $32.1K | 41.7% |
| 2 | FINISHED PHARMACEUTICAL PRODUCT - DILTIAZEM HYDROCHLORIDE TABLETS 60MG PACK STYLE 3X10 TAB BATCH NO. IT787A, IT787B | 1 | $13.7K | 17.8% |
| 3 | DILTIAZEM HYDROCHLORIDE TABLETS 60MG PACK STYLE 3X10 TAB BATCH NO. IT582 MFG DATE DEC-23 EXP DATE NOV-26NOS | 1 | $12.0K | 15.5% |
| 4 | PHARMACEUTICAL DRUGS & MEDICINES DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE CAPSULES USP 120 MG | 1 | $6.7K | 8.7% |
| 5 | DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE CAPSULES USP 120MG | 1 | $5.4K | 7.1% |
| 6 | DILTIAZEM HCL 90 MG SR TABLETS BATCH NO: H24402 MFG DATE: 11/2024, EXP DATE: 10/2027 | 1 | $3.0K | 3.9% |
| 7 | PHARMACUITICALS FINISHED PRODUCT-DILTIAZEM HYDROCHLORIDE TABLETS 60MG B.NO.IT127 | 1 | $2.3K | 3.0% |
| 8 | DILTIAZEM HCL 120 MG SR TABLETS BATCHNO: H24403 MFG DATE: 11/2024, EXP DATE:10/2027 | 1 | $1.8K | 2.4% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
AHEMDABAD AIR ACC (INAMD4) handles the highest volume with 2 shipments. Transit time averages 19 days by sea.
Market Dynamics
India's diltiazem exports to Ecuador are driven primarily by a handful of large-scale manufacturers. CARITAS HEALTHCARE PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Ecuador benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CARITAS HEALTHCARE PRIVATE LIMITED , CARITAS HEALTHCARE PRIVATE LIMITED, STALLION LABORATORIES PVT LTD — together account for 94% of total trade value on this route. The average shipment value of $8.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as finished pharmaceutical product - diltiazem hydrochloride tablets 60mg pack style 3x10 tab batch no. it787a, it787b and diltiazem hydrochloride tablets 60mg pack style 3x10 tab batch no. it582 mfg date dec-23 exp date nov-26nos, suggesting that buyers in Ecuador tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE PURCHASE MANAGER is the largest importer with 2 shipments worth $32.1K USD — representing 42% of all diltiazem imports from India on this route.
Route Statistics
- Trade Volume
- $77.1K
- Avg. Shipment
- $8.6K
- Suppliers
- 4
- Buyers
- 5
- Transit (Sea)
- ~19 days
- Annual Growth
- +17.1%
Other Diltiazem Routes
Unlock the Full India to Ecuador Diltiazem Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to Ecuador Diltiazem Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diltiazem to Ecuador?
The leading Indian exporters of Diltiazem to Ecuador are CARITAS HEALTHCARE PRIVATE LIMITED , CARITAS HEALTHCARE PRIVATE LIMITED, STALLION LABORATORIES PVT LTD. CARITAS HEALTHCARE PRIVATE LIMITED holds the largest market share at approximately 42% of total trade value on this route.
Q What is the total value of Diltiazem exports from India to Ecuador?
India exports Diltiazem to Ecuador worth approximately $77.1K USD across 9 recorded shipments. The average value per shipment is $8.6K USD.
Q Which ports does India use to ship Diltiazem to Ecuador?
The most active port of origin is AHEMDABAD AIR ACC (INAMD4) with 2 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Ecuador for Diltiazem?
The average transit time for Diltiazem shipments from India to Ecuador is approximately 19 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Ecuador Diltiazem trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 17.1% with demand growth tracking at 14.8%. The route is ranked #20 among India's top Diltiazem export destinations globally.
Q How many suppliers are active on the India to Ecuador Diltiazem route?
There are currently 4 active Indian suppliers exporting Diltiazem to Ecuador. The market is moderately concentrated with CARITAS HEALTHCARE PRIVATE LIMITED accounting for 42% of total shipment value.
Q Who are the main importers of Diltiazem from India in Ecuador?
The leading importers of Indian Diltiazem in Ecuador include TO THE PURCHASE MANAGER , F.D.E.C.A, NORTH LIFE PHARMA ECUADOR NLF C.T., DIFARMEDIC CIA. LTDA., FDECA QUITO ECUADOR. TO THE PURCHASE MANAGER is the largest buyer with 2 shipments worth $32.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Ecuador export trade corridor identified from Indian Customs (DGFT) records for Diltiazem.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 5 importers in Ecuador matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists